Vivo Capital IX, LLC 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:27 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Vivo Capital IX, LLC | 326,888 1.800% |
-326,891 (-50.00%) |
Filing |
| 2020-06-11 5:07 pm Purchase |
2020-06-01 | 13G | Larimar Therapeutics, Inc. LRMR |
Vivo Capital IX, LLC | 653,779 4.300% |
653,779 (New Position) |
Filing |